V

Virginia Eye Consultants | Norfolk, VA

Research site

(Unclaimed)

Location

241 Corporate Boulevard, Norfolk, Virginia, United States of America

Site insights

Top conditions

Top treatments

Dexamethasone Phosphate

KPI-121

Latanoprost

Netarsudil

LX201

AR-13324

Azithromycin

Abicipar Pegol

SUN-131

ISIS 2922

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 53 total trials

An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED

This is a phase 3, randomized, multicenter, double-masked, parallel group, vehicle-controlled prospective clinical trial to evaluate the safety and e...

Enrolling

Persistent Corneal Epithelial Defect

Other: Vehicle

Drug: Cenegermin

Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2

The objective of this study is to compare the safety and efficacy of RGN-259 to placebo for the treatment of Neurotrophic Keratopathy (NK)

Enrolling

Neurotrophic Keratopathy

Drug: Placebo

Drug: RGN-259

Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED) (ORBIT)

The goal of this clinical trial is to evaluate the efficacy, safety, and tolerability of linsitinib in participants with moderate to severe Thyroid E...

Enrolling

Thyroid Eye Disease, TED

Graves Orbitopathy

Drug: Placebo

Drug: linsitinib

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars

This study will enroll subjects with recently formed corneal scars that resulted from a corneal insult presenting and diagnosed within the past appro...

Enrolling

Corneal Scar

Biological: CSB-001 Ophthalmic Solution 0.1%

Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis (EYETAC)

The primary objective of the study is to investigate the safety and tolerability of NOV05 eye drops at two concentrations QID in patients with active...

Enrolling

Non-infectious Anterior Uveitis

Drug: Tacrolimus ophthalmic solution